Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer

被引:1
|
作者
Declercq, Isabelle [1 ,2 ]
Lievens, Yolande
Verbeken, Eric
Vansteenkiste, Johan [1 ,2 ]
机构
[1] Univ Hosp Gasthuisberg, Resp Oncol Unit Pulmonol, B-3000 Louvain, Belgium
[2] Univ Hosp Gasthuisberg, Leuven Lung Canc Grp, B-3000 Louvain, Belgium
关键词
pemetrexed; rash; non-small cell lung cancer; radiotherapy;
D O I
10.1097/JTO.0b013e318170fcb9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:662 / 663
页数:2
相关论文
共 50 条
  • [11] Mechanisms of Gefitinib Plus Pemetrexed on Human Non-Small Cell Lung Cancer
    Lou, Y.
    Xu, J.
    Zhang, Y.
    Lu, J.
    Zhang, X.
    Wang, H.
    Zhang, W.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S957 - S957
  • [12] Establishment of pemetrexed-resistant non-small cell lung cancer cell lines
    Zhang, Dan
    Ochi, Nobuaki
    Takigawa, Nagio
    Tanimoto, Yasushi
    Chen, Yanyan
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER LETTERS, 2011, 309 (02) : 228 - 235
  • [13] Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer
    Bearz, Alessandra
    Garassino, Isabella
    Tiseo, Marcello
    Caffo, Orazio
    Soto-Parra, Hector
    Boccalon, Massimo
    Talamini, Renato
    Santoro, Armando
    Bartolotti, Marco
    Murgia, Viviana
    Berretta, Massimiliano
    Tirelli, Umberto
    LUNG CANCER, 2010, 68 (02) : 264 - 268
  • [14] Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
    K Takezawa
    I Okamoto
    W Okamoto
    M Takeda
    K Sakai
    S Tsukioka
    K Kuwata
    H Yamaguchi
    K Nishio
    K Nakagawa
    British Journal of Cancer, 2011, 104 : 1594 - 1601
  • [15] Pemetrexed and cyclophosphamide combination therapy for the treatment of non-small cell lung cancer
    Li, Dong
    He, Song
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14693 - 14700
  • [16] Role of Pemetrexed and Platinums Combination in Patients with Non-Small Cell Lung Cancer
    Chen, Manyin
    Shao, Wenlong
    He, Jianxing
    Wang, Daoyuan
    CURRENT DRUG TARGETS, 2010, 11 (01) : 29 - 36
  • [17] A Phase II Study of Oxaliplatin, Pemetrexed, and Bevacizumab in Previously Treated Advanced Non-small Cell Lung Cancer
    Heist, Rebecca Suk
    Fidias, Panos
    Huberman, Mark
    Ardman, Blair
    Sequist, Lecia V.
    Temel, Jennifer S.
    Lynch, Thomas J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) : 1153 - 1158
  • [18] The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer
    Konopa, Krzysztof
    Jassem, Jacek
    CURRENT DRUG TARGETS, 2010, 11 (01) : 2 - 11
  • [19] Toxic Epidermal Necrolysis after Pemetrexed and Cisplatin for Non-Small Cell Lung Cancer in a Patient with Sharp Syndrome
    Then, Cornelia
    von Einem, Jobst C.
    Mueller, Daniel
    Flaig, Michael J.
    Huber, Rudolf M.
    Reincke, Martin
    ONKOLOGIE, 2012, 35 (12): : 783 - 786
  • [20] Recurrence patterns of advanced non-small cell lung cancer treated with gefitinib
    Chen Min-jiang
    Zhong Wei
    Zhang Li
    Zhao Jing
    Li Long-yun
    Wang Meng-zhao
    CHINESE MEDICAL JOURNAL, 2013, 126 (12) : 2235 - 2241